Journal
PAPILLOMAVIRUS RESEARCH
Volume 4, Issue -, Pages 35-38Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.pvr.2017.06.002
Keywords
Human papillomavirus (HPV); Vaccination; Immunocompromised hosts; HPV related cancers; HPV Guidelines
Categories
Funding
- World Health Organization [001] Funding Source: Medline
Ask authors/readers for more resources
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
